Navigation Links
Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
Date:3/22/2013

NANJING, China, March 22, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Chinese SFDA has issued its approval for GMP certification of the influenza vaccine production facility at Jiangsu Simcere Vaxtec Bio-Pharmaceutical Co., Ltd ("Simcere Vaxtec"), a subsidiary in which the Company holds a 52.5% equity interest. Simcere Vaxtec plans to resume production of its influenza vaccine.

Separately, the Company also announced the resignation of Mr. Hong Zhao , an executive vice president of the Company. Mr. Zhao resigned for personal reasons. His resignation has been accepted by the Company and will take into effect on April 1, 2013.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.

Investor and Media Contacts:

Email: ir@simcere.com

In Nanjing:

'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Legal Counsel
2. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
3. Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results
4. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
5. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
7. Simcere Pharmaceutical Group to Announce Third Quarter 2012 Financial Results on Thursday, November 15, 2012
8. Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
9. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
10. Simcere Pharmaceutical Group to Announce Second Quarter 2012 Financial Results on Friday, August 10, 2012
11. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Mass. and JERUSALEM , ... biopharma company developing octreotide capsules, its lead product for ... a $70 million Series E financing round. Participants in ... Sofinnova Ventures, and an undisclosed blue chip public investment ... Capital, 7 Med Health Ventures, Abingworth and ARCH Venture ...
(Date:2/26/2015)... NORTH CHICAGO, Ill. , Feb. 26, 2015 ... announced that 15 abstracts of studies in its ... for presentation during the 67 th American ... Washington, D.C. , from April 18-25. The ... FDA-approved product, DUOPA, in addition to investigational treatments ...
(Date:2/26/2015)... , Feb. 26, 2015 Legislation passed ... a pharmacy provision to help prevent inappropriate prescriptions in ... Protecting the Integrity of Medicare Act (PIMA) of ... Chairman Kevin Brady (R-TX) and Ranking Member ... prescription drug abuse epidemic and implement the right policies, ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... Corporation ( Unilife or Company ) (Nasdaq: ... Share Purchase Plan ( SPP ), which closed on Wednesday, ... applications for approximately 15.1 million new CHESS Depositary Interests ( ... representing an interest in one sixth of a share of ...
... NEW YORK, Dec. 30, 2010 InstaCare Corp. (OTC ... of the Shasta Genstrip diagnostic testing strips, a leading ... for the chronically ill, as well as leading fulfillment ... developer of revolutionary cell phone centric e -health ...
Cached Medicine Technology:Unilife Receives SPP Applications Exceeding A$12.8 Million 2Unilife Receives SPP Applications Exceeding A$12.8 Million 3Unilife Receives SPP Applications Exceeding A$12.8 Million 4InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011 2
(Date:2/28/2015)... AB (PRWEB) February 28, 2015 The ... is now a distributor of the machine. The Heart ... of their license, like a franchise model. The goal ... prevent and reverse heart disease. To buy External ... Fit Clinic can help individuals through this process and ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax accounting ... consulting services in addition to a variety of other ... planning. Company finances are a complicated matter that should ... this, complex Canadian tax laws can make it even ... Mew and Company works to advise their clients on ...
(Date:2/28/2015)... A study out of the University of ... for the treatment of a hereditary ocular condition that ... by Dr. Robert MacLaren, professor of ophthalmology at the ... Journal on January 16, 2014 , the study treated ... that mostly affects men and leads to the degeneration ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Pioneer Millworks ... 2015 Japan Architecture & Construction Materials Show, an annual, ... more than 1,000 suppliers and top manufacturers of the ... Reclaimed wood products sourced and manufactured by Pioneer ... found popularity in Japan at restaurants, hotels, retailers, and ...
(Date:2/28/2015)... 28, 2015 India Network Foundation, ... visitor health insurance programs for visitors coming to the ... elderly parents traveling to the United States are suffering ... and blood pressure. These diseases are so common among ... them as medical conditions. There were 66.8 million cases ...
Breaking Medicine News(10 mins):Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
Statistics released by the Scottish Executive show that around 2.9 million clean needles were dispensed for drug users, but only 1.9 million were returned thus sparking a shortage of a million needles...
... become stagnant in our body result in Colon cancer. He received ... tissue cells can be damaged if the wastes are not removed ... cells become weak and unhealthy. One should have a bowel movement ... have shown that if you have a bowel movement every 3 ...
... Mouse population has been on the rise past two winters, ... field days for the scurrying mouse. Infact mouse proliferation has ... fallout of poor hygiene in mice habitats. ,Some ... fever, muscle aches, nausea, cough and abdominal pain, which surface ...
... it was appropriate for Rahul Mahajan to be taken to ... to Apollo hospital and not to AIIMS or Safdarjang even ... overdosing. //But medical experts say drug overdosed patients should be ... treated, the better are the chances of their survival. ...
... Melbourne University has launched a plan to improve the bedside ... effect, the medical students will be "embedded" with patients suffering ... two years. // ,This program will be compulsory ... Harvard Medical School in the US. "I think it would ...
... has been invited by non-resident Indians (NRIs) in Mauritius to tie ... be held June 18. // ,Ajeetpal Singh, who has a ... to tie 125 turbans or "safas" for a marriage ceremony. And ... hours. ,Singh plunged into this art at the age ...
Cached Medicine News:Health News:The myth about government hospitals 2
... laboratory-grade pure water at a constant flow ... tap water and combine complementary purification technologies ... easy to operate, reliable, and allows total ... low operating cost., Applications, Glassware rinsing ...
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... Keep your samples secure in our largest ... storage - enough for 52,700 samples -- ... this ultra-low temperature model utilizes ultra-thin vacuum ... and minimize the footprint. Patented Tollesbury Technology ...
... RiOs systems produce Type III, laboratory-grade ... Systems are fed directly with potable tap ... a compact system design that is easy ... over the water produced at a low ...
Medicine Products: